BioCentury
ARTICLE | Company News

Elan counter offers for Quadrant

October 27, 2000 7:00 AM UTC

ELN and drug delivery company Quadrant (LSE:QTH) said they have agreed on terms of an offer by ELN to buy QTH for 75p per QTH share, valuing QTH at 52.3 million ($75.9 million). The move follows last ...